Takotsubo syndrome is increasing in incidence and becoming more widely recognized in the medical community. The diagnosis can be challenging, and clinicians must look for signs distinguishing takotsubo syndrome from other causes of acute myocardial injury. The use of multimodality imaging may help in this regard and improve our understanding of its underlying pathogenesis and pathophysiology. At present, takotsubo syndrome remains a poorly understood condition with substantial morbidity and mortality without proven or effective treatments that urgently need to be addressed.
Sources of Funding
Dr Singh is supported by the British Heart Foundation (RE/18/5/34216) and Medical Research Council (MR/T-29/53/1). Dr Newby is supported by the British Heart Foundation (CH/09/002, RG/16/10/32375, RE/18/5/34216) and is the recipient of a Wellcome Trust Senior Investigator Award (WT103782AIA). Dr Gamble is supported by the British Heart Foundation (PG/18/35/33786). Dr Dawson is supported by the British Heart Foundation (FS/RTF/20/30009, NH/19/1/34595, PG/18/35/33786, CS/17/4/32960, PG/15/88/31780, PG/17/64/33205), Chest Heart and Stroke Scotland (19/53), Tenovus Scotland (G.18.01), Friends of Anchor and Grampian NHS-Endowments.
Circulation. 2022;145(13):1002-1019. © 2022 American Heart Association, Inc.